XCR1: A Gene Implicated in Immune Response and Disease (G2829)

Target Name: XCR1

NCBI ID: G2829

XCR1

XCR1: A Gene Implicated in Immune Response and Disease

XCR1 (XCR1_HUMAN), also known as human X-chromosome complex region 1, is a gene that encodes a protein known as XCR1. XCR1 is a key regulator of the immune response and has been implicated in a number of diseases, including cancer.

The XCR1 gene was first identified in 2007 and has since been extensively studied. It is located on the X chromosome, which is one of the two sex chromosomes that exist in humans. The X chromosome carries the majority of the genetic information for the body and is responsible for the development and maintenance of many normal functions, including the immune response.

XCR1 is a protein that plays a crucial role in the regulation of the immune response. It is expressed in many different tissues and cells of the body, including the blood cells, the epithelial tissue, and the immune cells. XCR1 is involved in the development and maintenance of the T cells, which are a critical part of the immune system.

One of the most promising aspects of XCR1 is its potential as a drug target. Researchers have identified several potential drug-associated targets for XCR1 and are currently exploring the use of small molecules and other compounds to target this protein.

One of the most promising targets for XCR1 is the XCR1-CDK2 interaction, which is a complex that regulates the growth and differentiation of T cells. The XCR1-CDK2 interaction is a key regulator of the T-cell receptor, which is a critical part of the immune system.

Research has shown that the XCR1-CDK2 interaction is regulated by XCR1 itself. By inhibiting the activity of XCR1, researchers have been able to reduce the activity of the T-cell receptor and improve the function of T cells. This suggests that XCR1 may be an attractive target for drugs that are designed to enhance the immune response.

Another promising target for XCR1 is the XCR1-SSG3 interaction, which is a complex that regulates the migration and adhesion of immune cells. The XCR1-SSG3 interaction is a key regulator of the chemokine receptor, which is a critical part of the immune system.

Research has shown that the XCR1-SSG3 interaction is regulated by XCR1 itself. By inhibiting the activity of XCR1, researchers have been able to reduce the activity of the chemokine receptor and improve the migration and adhesion of immune cells. This suggests that XCR1 may be an attractive target for drugs that are designed to enhance the immune response.

In addition to its role in the immune system, XCR1 is also involved in the regulation of cell growth and differentiation. It is a known regulator of theNotch signaling pathway, which is a critical part of the immune system.

The Notch signaling pathway is a critical regulator of cell growth and differentiation. It is involved in the regulation of many different cell processes, including the development and maintenance of tissues and organs, as well as the regulation of cell growth and differentiation.

Research has shown that XCR1 is involved in the regulation of Notch signaling pathway. By activating the Notch signaling pathway, XCR1 has been shown to promote the development and maintenance of tissues and organs, as well as the regulation of cell growth and differentiation.

In conclusion, XCR1 is a gene that encodes a protein that plays a crucial role in the regulation of the immune response and has been implicated in a number of diseases. Its potential as a drug target is currently being explored by researchers, who are seeking to identify small molecules and other compounds that can inhibit the activity of XCR1. Further research is needed to understand the full role of XCR1 in the immune system and to develop effective treatments for the diseases associated with its dysfunction.

Protein Name: X-C Motif Chemokine Receptor 1

Functions: Receptor for chemokines SCYC1 and SCYC2. Subsequently transduces a signal by increasing the intracellular calcium ions level. Receptor for XCL1/Lymphotactin

The "XCR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XCR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets